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THE EFFECT OF HISTAMINE ON THE PULMONARY CIRCULATION IN MANIf
The influence of intra-alveolar pressure and respiratory mechanics on
pulmonary hemodynamics has been extensively studied.' Rodbard has pre-
sented the view that bronchomotor tone is a prominent factor in the regula-
tion of pulmonary blood flow,' but the effect of bronchoconstriction on
pulmonary pressure and flow has, so far, been studied very little in humans.'
If the pulmonary hypertension observed in patients with broncho-obstructive
disease is to be ascribed, even in part, to the obstruction itself, then one
should be able to influence cardiac output or pulmonary vascular resistance
by administering agents known to produce bronchospasm.
The present study was designed to demonstrate the effect of histamine on
pulmonary hemodynamics in a group of hospital patients with chronic
bronchitis, pulmonary emphysema, or other lung diseases associated with
impaired ventilation. It was hoped that the drug would produce in these
patients a disproportionate bronchoconstriction even in doses having only
slight primary circulatory effect. Effects ranging from no bronchoconstric-
tion to severe bronchoconstriction were anticipated, however, because of
individual variation in homeostatic reflexes and bronchial musculature
sensitivity to histamine. The observations presented here describe the
circulatory and ventilatory changes produced by small doses of histamine in
patients selected on the basis of having chronic pulmonary disease.
MATERIAL AND METHODS
Twenty-one ambulatory, male hospital patients with chronic pulmonary disease were
studied. Spirometry and cardiac catheterization were performed on consecutive days
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before and after the subcutaneous injection of 0.6 to 0.8 mg. of histamine phosphate.
All subjects had performed the ventilatory tests previously and were thus familiar with
the procedures.
On the first day, vital capacity and maximum breathing capacity were measured with
the patient supine on a bed gatched 30 degrees from the horizontal, and blood pressure
was measured. After a satisfactory baseline record had been obtained, the histamine
TABLE 1. CLINIcAL DATA
Body Dose of
surface histamine
area phosphate
Patient Age Diagnosis Sq.M. mgm.
M. M. 39 Tuberculous pleurisy 1.81 0.75
G. L. 69 Pulmonary emphysema, bronchiectasis 1.81 0.80
H. D. 55 Pulmonary emphysema, chronic bronchitis 2.32 0.80
G. G. 69 Pulmonary emphysema, bronchiectasis 1.56 0.70
F. B. 63 Chronic bronchitis, polycythemia 2.17 0.80
D. B. 56 Pulmonary emphysema, chronic bronchitis 1.79 0.60
T. A. 62 Pulmonary emphysema, chronic bronchitis 1.73 0.60
J. M. 62 Mitral stenosis and insufficiency 1.82 0.60
H. W. 56 Chronic bronchitis, liver cirrhosis 1.86 0.60
P. R. 37 Pulmonary tuberculosis 1.68 0.80
W. P. 51 Pulmonary emphysema, chronic bronchitis 1.88 0.70
P. Z. 51 Pulmonary tuberculosis 1.38 0.70
W. M. 32 Chronic bronchitis 1.86 0.80
D. C. 65 Chronic bronchitis, cor pulmonale 1.60 0.60
A. L. 60 Pulmonary emphysema, bronchiectasis 1.55 0.60
G. F. 39 Bronchiectasis 1.80 0.60
F. S. 32 Pulmonary tuberculosis 1.76 0.70
F. F. 60 Pulmonary emphysema, bronchiectasis 1.78 0.70
N. M. 64 Pulmonary emphysema, bronchiectasis 1.98 0.70
P. S. 37 Pulmonary emphysema, chronic bronchitis 1.79 0.70
E. U. 59 Pulmonary emphysema 1.60 0.70
H. A. 45 Pulmonary emphysema, bronchiectasis 1.66 0.70
was injected. Blood pressure was then measured every minute for 15 minutes. Vital
capacity and maximal breathing capacity were measured at 3, 7, and 11 minutes. On
the following morning cardiac catheterization was performed by standard methods.
Cardiac output was estimated by the direct Fick method. Following baseline measure-
ments, histamine in the same dose as that used on the previous day was injected
subcutaneously. Pulmonary artery pressures were then recorded every minute, and at
the time of maximum histamine effect, as observed during the spirometric studies the
previous day, a wedge pressure was recorded. Immediately after, cardiac output was
again estimated by the Fick method. Recording of pulmonary artery pressure continued
at minute intervals until 15 minutes after the injection. The method of Pederson and
Husby was used to establish the zero reference level for the pulmonary pressures.'
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A five-minute sample of expired air (while the subject breathed room air) was
obtained simultaneously with the slow withdrawal of blood samples from the femoral
and proximal pulmonary arteries. The expired air was analyzed by the Scholander
microanalysis technique, and the blood samples by the Roughton-Scholander method.
Arterial carbon dioxide content was measured, using the Kopp-Natelson microgasom-
eter, and arterial pH estimated at body temperature by means of a water-jacketed glass
electrode and a Cambridge Research Model pH Meter. The carbon dioxide tension was
determined from the Singer Hastings nomogram. Alveolar oxygen tension was calcu-
lated using the alveolar air equation, arterial oxygen tension read from the oxygen
dissociation curve, and the alveolar-arterial oxygen tension gradient calculated from
these data.
RESULTS
Tables 2 to 4 show the observed effects of histamine on vital capacity,
maximal breathing capacity, minute breathing volume, alveolar ventilation,
heart rate, systemic, pulmonary artery, and pulmonary wedge pressures,
cardiac output (expressed as cardiac index), total systemic and pulmonary
arterial resistances, arterial oxygen saturation, arterial oxygen tension,
alveolar-arterial oxygen tension gradient, and respiratory fluctuations in
pulmonary artery systolic and diastolic pressures.
Evaluation of the results showed a statistically significant fall in vital
capacity and maximal breathing capacity. The minute volume of ventilation
increased in most cases. The alveolar ventilation did not, however, show any
significant change in those cases in which it was measured.
The heart rate showed a significant increase, the systemic blood pressure,
a fall. The fall in pulmonary artery pressure was also significant, while there
was no significant change in pulmonary wedge pressure. Since the average
increase in cardiac index from 4.11 to 4.45 liters per minute was not statisti-
cally significant, calculated systemic and pulmonary resistance dropped.
There was a statistically significant increase both in systolic and diastolic
pulmonary artery pressure respiratory fluctuations.
The blood gas studies showed a significant fall in arterial oxygen
saturation, no changes in arterial carbon dioxide tension, and a significant
increase in the alveolar-arterial oxygen tension gradient. No significant
changes in oxygen capacity were noted. In nearly all patients a slight facial
flush was observed after histamine, and about one-half of the patients
experienced a mild headache.
DISCUSSION
1. Ventilation
Histamine in nontoxic doses has no effect on the mechanics of breathing
in the normal subject. In patients with asthma or some types of chronic lung
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disease, however, it has a powerful bronchomotor action; the systemic effects
of the drug in these patients are similar to those in the normal subject.6'
A fall in vital capacity after histamine has been found in studies of asthmatic
individuals.6 ""' An increase in respiratory minute volume," a decrease in
lung compliance,'9 and an increase in airway resistance'8 have been observed
in patients with chronic pulmonary disease. Our data agree with these
observations. It should be noted, however, that in some of our patients the
vital capacity did not fall more than 100 ml. or even increased after hista-
mine; inonly nine cases did thevital capacity decrease more than 10 per cent.
Furthermore, maximal breathing capacity did not decrease in all of our
patients. Alveolar ventilation did not show statistically significant changes
in those cases in which it was calculated. A variable effect of histamine on
ventilatory function, according to the severity of disease, has been observed
by others.' The bronchoconstrictor effect of histamine in the dosage used
was not demonstrated in all of our patients. Our purpose, however, was to
use relatively small amounts of the drug in order to limit its systemic effect.
There are reflexes which serve to maintain a steady state when broncho-
constriction occurs. Most notable are the presso-receptors of the lung which
react to increased expiratory pressure by increasing inspiratory effort and
the resting volume of the lung. This passively dilates the constricted
bronchi; thus, in the intact human subject, bronchospasm may be elusive.
Since bronchoconstriction occurred in some of the patients and not in
others, any consistent circulatory change must be unrelated to the broncho-
constricting effect of histamine.
2. Systemic circulation
The observed effects on the systemic circulation are in agreement with
earlier investigations in man. Weiss, Robb, and Ellis,' Wakim, Peters,
Terrier, and Horton,8' and Peters and Horton8' found an increase in heart
rate on the intravenous infusion of histamine, while a fall in systemic blood
pressure was observed by Wilber and Brust.' Roth and Kvale' gave a single
intravenous dose of 0.025-0.05 mgm. of histamine base and observed a slight
rise after an initial drop in blood pressure. An increase in cardiac output
following histamine was observed by Weiss et al.,' while Wakim et al.'
found an increase in blood flow in all four extremities, as demonstrated by
venous occlusion plethysmography. The rise in cardiac output observed in
our studies was not statistically significant. This variable effect of the drug
may be due to a difference in dose. In the dog under general anesthesia, small
doses induce capillary dilatation and an increase in blood flow; larger doses,
by further dilatation of the capillaries and small veins, produce a pooling of
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blood in the periphery, with reduction of the venous return and of the
cardiac output.' However, independent of the doses used, the circulatory
effects of histamine vary greatly in different species according to the method
of administration and the organs primarily affected.
TABLE 4. RATE, FLOW, AND RESISTANCE DATA
Heart rate
Patient B A
M.M. 88 94
G.L. 63 80
H.D.
G.G. 92 96
F.B. 84 90
D.B. 120 120
T.A. 72 80
J.M- 80 90
H.W. 110 115
P.R. ... ...
W.P. ... ...
P.Z. 75 75
W.M. 62 62
D.C. ... ...
A.L. 84 76
G.F. 104 108
F.S. ... ...
F.F. 90 95
N.M. 100 100
P.S. 66 78
E.U. ... ...
H.A. ... ...
Systemic
blood flow
LlminIM'
B A
6.1 5.1
3.4 3.7
2.6 2.9
8.9 7.1
4.4 4.6
3.2 5.1
4.3 4.3
2.9 2.8
2.5 2.0
4.6 6.8
3.3 3.7
5.5 3.6
5.7 5.0
3.0 3.5
2.7 2.7
5.5 7.0
4.9 5.9
3.3 2.9
3.2 3.1
3.2 6.8
3.1 4.0
4.2 5.4
Total periph- Pulmonary artery
eral resistance resistance
dynes-sec.-cm.' dynes-sec.-cm.'
B A B A
756 740 ... ...
1200 1070 184 124
1420 1280
480 540 80 108
545 520 96 80
1284 794 172 106
1160 950 81 65
860 930 ...
1490 1690 167 159
1066 541 219 38
1280 1066 128 98
900 1000 73 80
1360 1340
1380 1200 ... ...
1520 1330 150 114
560 430 56 38
1278 1225 148 168
942 776 ... ...
1040 435 84 33
1965 1025 109 82
.... - .... ...- * ...*-
Mean 86 90.6 4.11 4.45 1124 944 125 92
Diff. 10.1 0.28 182 32.4
t 5.29 1.04 2.77 8.67
P<0.001 0.400>P>0.200 0.025>P>0.010 P<0.001
Although the parameters of systemic circulation which were measured did
not show impressive changes, there was a trend toward a lower peripheral
resistance after histamine. A lower resistance could lead to peripheral
pooling of blood and a consequent drop in cardiac output. This was pre-
vented by a rise in heart rate, thus homeostatic reflexes make it difficult to
evaluate, quantitatively, changes in any one function.
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3. Pulmonary circulation
To our knowledge, direct measurements of the effect of histamine on the
pulmonary circulation in humans have not been reported. Different results
have been observed in animals of different species, but it would be unwise
to transfer such observations to humans. In rodents the predominant effect
of histamine is bronchoconstriction; in cats, arterial vasoconstriction. In
recent observations from this laboratory,28 the intravenous injection of
histamine in the anesthetized dog was found to induce an initial rise in
pulmonary artery pressure, followed by a fall which was secondary to a drop
in cardiac output. In the unanesthetized dog the increased pulmonary artery
pressure has been interpreted as a passive result of an initial increase in
venous return."'5 In the isolated dog lung preparation, histamine also causes
pulmonary hypertension; the increased resistance is apparently due to pul-
monary vein constriction.' The effects of the drug on the airway volume and
on the pulmonary blood volume are apparently independent of one another.'
In rigidly controlled experimental conditions, however, with the lungs per-
fused artificially in situ through two separate cannulas, bronchoconstriction
was associated with an increase in resistance to flow.8
Our findings in the pulmonary circulation were qualitatively similar to
those in the systemic circulation. The wedge pressure showed no changes,
suggesting that in our experiments pulmonary venous resistance did not
increase. There were no significant changes in cardiac output, hence the
hemodynamic effects of histamine on the pulmonary circulation are probably
not passive results of its action on the systemic circulation. However,
changes in distribution of blood may have occurred after the administration
of histamine and between our consecutive measurements of cardiac output.
For the purpose of analysis of the circulatory effects of histamine, we have
arbitrarily segregated those patients in whom the decrease in vital capacity
was greater than 10 per cent. Although there are quantitative differences, the
hemodynamic changes following administration of the drug in the subgroup
of patients showing evidence of bronchoconstriction are essentially similar
to those observed in the whole group. This suggests that, in our experiments,
the bronchomotor effect of histamine has no measurable influence on the
pulmonary arterial pressure.
The increased respiratory fluctuations in pulmonary arterial pressure have
been interpreted as evidence of increased airway resistance.2'13'14 In order
to analyze the mechanism of the respiratory swing, it is necessary to remove
the influence of the intrathoracic pressure itself from the measurement of
vascular pressure. To accomplish this the intrathoracic pressure must be
subtracted algebraically from the observed gross vascular pressure, thus
providing a "net" pulmonary artery pressure.8 There was no difference
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between the pulmonary artery pressure fluctuations of those patients who
had evidence of bronchoconstriction and those who did not. and the pul-
monary artery resistance decreased even in patients who showed broncho-
constriction; therefore, one must conclude that respiratory fluctuations do
not reflect an effect of bronchoconstriction on pulmonary hemodynamics.
Rather, it would appear, these fluctuations represent the algebraic sum of
intrathoracic and intravascular pressure variations. This does not rule out
the possibility that some types of bronchoconstriction could alter blood flow
or resistance. The site of bronchial constriction or relaxation, whether
involving primarily the large or small bronchi, must be determined if the
relationship between bronchomotor tone and pulmonary hemodynamics is to
be understood.9 However, the bronchospastic effect of histamine has been
shown to be similar to that of true asthma.' In view of this, the present
studies cast doubt on the role of bronchospasm as a cause of increased
pulmonary vascular resistance leading to pulmonary hypertension in patients
with chronic asthma.
4. Alveolar-arterial oxygen tension gradient
A significant fall in arterial oxygen saturation was observed, but no
change in arterial carbon dioxide tension. The alveolar-arterial oxygen
tension gradient showed a rise. These changes in blood gas values have been
reported by others,1' 178 who found a fall in arterial oxygen saturation after
1 to 1.5 mgm. of histamine in patients with heart and lung diseases. Tang'
also observed a widening of the alveolar-arterial oxygen tension gradient
following histamine. These workers were of the opinion that the observed
changes in blood gas values were due to a thickening of the alveolar-capillary
membrane.
The fall in arterial oxygen saturation seen in our patients was not
produced by alveolar hypoventilation, as the arterial carbon dioxide tension
was not elevated, nor was the alveolar ventilation changed after histamine.
An increase in alveolar-arterial oxygen tension gradient might be due to a
thickening of the alveolar-capillary membrane or an increase in venous
admixture. Experiments have been carried out to study the possibility of
venous admixture. After establishing the resting arterial oxygen saturation,
patients were given 100 per cent oxygen to breathe following histamine
administration. They all showed a rise in arterial oxygen saturation to 100
per cent during oxygen breathing. These experiments tend to exclude a
venous admixture following histamine. Animal experiments showing an
increase in lung weight following histaminel' suggest that the drug causes
capillary dilatation, possibly also edema. This would increase the distance
between the alveolar space and the hemoglobin and impair oxygen diffusion.
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Transudation of plasma across the capillary wall and an increased concen-
tration of hemoglobin have been noted by others, both in the systemic,"'
and in the pulmonary circulation.17 This effect was not noted in our patients,
however, possibly because of the low dose of histamine used. The influence
of histamine on arterial oxygen saturation and tension has already been
applied in a test attempting to augment borderline central cyanosis in
patients with various disorders.''16"7
One probable explanation for the widening of the alveolar-arterial oxygen
tension gradient observed in the present study is that a disturbance occurred
in the ventilation-to-perfusion ratio. If perfusion increased greatly while
ventilation did not, the alveolar-arterial oxygen tension gradient might be
expected to increase. Hypoventilation alone does not seem a likely cause of
the phenomenon, since the arterial carbon dioxide tension did not rise, but
rather fell after histamine.
SUMMARY
Twenty-one patients with various chronic lung diseases have been studied.
Ventilation and pulmonary hemodynamics have been observed following the
subcutaneous administration of histamine phosphate. A pronounced decrease
in maximal breathing capacity and vital capacity occurred in nine.
There was an increase in heart rate, a fall in systemic blood pressure and
peripheral arterial resistance, but no change in cardiac output. A vasodilator
effect of histamine was also demonstrated in the pulmonary circulation, with
a fall in pulmonary artery mean pressure and pulmonary arterial resistance,
but no change in pulmonary arter-y wedge pressure. The increase in broncho-
motor tone produced by histamine in some patients did not measurably
influence the pressures or resistance in the pulmonary circulation. The
concept that pulmonary hypertension may be the direct effect of broncho-
obstructive disease cannot be supported by these findings.
Arterial oxygen saturation fell, but little change occurred in arterial
carbon dioxide tension. The alveolar-arterial oxygen tension gradient rose.
The latter was probably the result of capillary dilatation and alteration of
the ventilation: perfusion relationship produced by histamine.
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